DCGI has asked the Serum Institute of India to stop recruiting candidates for the corona vaccine test until further orders. DCGI has said that it should stop the recruitment of new candidates for the second and third phase of clinical trials in the wake of the drug company AstraZeneca stopping the testing of the Oxford Covid-19 vaccine in other countries until further orders.
Controller General VG Somani, in an order on Friday, also asked the Serum Institute of India (SII) to increase the safety monitoring of those who were still vaccinated during the test. Also present plans and reports.
As per the order, Somani has also asked the company to submit the approval from the Data and Safety Monitoring Board (DSMB) in the UK and India for prior approval from their office (DCGA) before making new recruits for future tests. .
The DCGA issued a show cause notice to SIE on September 9 for not providing information about AstraZeneca’s withholding of vaccines in other countries.
